PH26527A - Method and therapeutic compositions for the prevention of fibrin depositions or adhesions - Google Patents

Method and therapeutic compositions for the prevention of fibrin depositions or adhesions Download PDF

Info

Publication number
PH26527A
PH26527A PH37149A PH37149A PH26527A PH 26527 A PH26527 A PH 26527A PH 37149 A PH37149 A PH 37149A PH 37149 A PH37149 A PH 37149A PH 26527 A PH26527 A PH 26527A
Authority
PH
Philippines
Prior art keywords
vehicle
plasminogen activator
tissue plasminogen
enzyme
inert
Prior art date
Application number
PH37149A
Other languages
English (en)
Inventor
Marjorie A Mohler
Tue H Nguyen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of PH26527A publication Critical patent/PH26527A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH37149A 1987-07-01 1988-07-01 Method and therapeutic compositions for the prevention of fibrin depositions or adhesions PH26527A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6887287A 1987-07-01 1987-07-01
US12531987A 1987-11-25 1987-11-25
US21089588A 1988-06-24 1988-06-24

Publications (1)

Publication Number Publication Date
PH26527A true PH26527A (en) 1992-08-07

Family

ID=27371438

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37149A PH26527A (en) 1987-07-01 1988-07-01 Method and therapeutic compositions for the prevention of fibrin depositions or adhesions

Country Status (14)

Country Link
EP (1) EP0297860B1 (ko)
JP (1) JP2756131B2 (ko)
KR (1) KR0131330B1 (ko)
AU (1) AU621305B2 (ko)
DE (1) DE3883645T2 (ko)
DK (1) DK175597B1 (ko)
FI (1) FI103868B1 (ko)
IE (1) IE65658B1 (ko)
IL (2) IL86933A (ko)
NO (1) NO301748B1 (ko)
NZ (1) NZ225260A (ko)
PH (1) PH26527A (ko)
PT (1) PT87886B (ko)
WO (1) WO1989000049A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
WO1995001292A1 (en) * 1993-07-02 1995-01-12 Quest International Bv. Packaging of enzymes
US5869810A (en) * 1995-05-23 1999-02-09 Victor Reynolds Impedance-heated furnace
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
US7067485B2 (en) 1997-11-07 2006-06-27 Chiron Corporation IGF-I composition and its use
WO1999024062A1 (en) * 1997-11-07 1999-05-20 Chiron Corporation Novel igf-i composition and its use
FR2918276B1 (fr) 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
JPS6218742A (ja) * 1985-07-18 1987-01-27 Sony Corp ヒ−トシンクの製造方法
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
KR870005646A (ko) * 1985-12-16 1987-07-06 로버트 엘. 미니어 수술후 유착형성 억제방법

Also Published As

Publication number Publication date
KR890701124A (ko) 1989-12-19
NO895338D0 (no) 1989-12-29
JP2756131B2 (ja) 1998-05-25
NO301748B1 (no) 1997-12-08
DK675389D0 (da) 1989-12-29
DE3883645T2 (de) 1994-02-03
DE3883645D1 (de) 1993-10-07
FI896359A0 (fi) 1989-12-29
IE65658B1 (en) 1995-11-15
IL102625A0 (en) 1993-01-14
FI103868B (fi) 1999-10-15
FI103868B1 (fi) 1999-10-15
PT87886A (pt) 1989-06-30
WO1989000049A1 (en) 1989-01-12
JPH04502753A (ja) 1992-05-21
NO895338L (no) 1990-02-28
NZ225260A (en) 1991-03-26
KR0131330B1 (ko) 1998-04-17
DK675389A (da) 1990-02-28
EP0297860B1 (en) 1993-09-01
IL86933A (en) 1993-07-08
IE882023L (en) 1989-01-01
DK175597B1 (da) 2004-12-13
AU1998588A (en) 1989-01-30
PT87886B (pt) 1993-09-30
EP0297860A1 (en) 1989-01-04
AU621305B2 (en) 1992-03-12

Similar Documents

Publication Publication Date Title
Tang et al. Peritoneal adhesions: Occurrence, prevention and experimental models
Liu et al. Crosslinked hyaluronan hydrogels containing mitomycin C reduce postoperative abdominal adhesions
EP0814774B1 (en) Reduction of adhesions using controlled delivery of active oxygen inhibitors
US5073378A (en) Processes for the preparation of storage stable collagen products
AU737312B2 (en) Treatment and prevention of adhesions
JP2006193535A (ja) フィブリン溶解増強剤の局所送達
AU621305B2 (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
JP2008264495A (ja) 術後癒着の防止及び腔内担体装置としてのヒドロキシエチルスターチの使用
US5364622A (en) Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
Diamond et al. Adhesion reformation: reduction by the use of Interceed (TC7) plus heparin
JPH04211019A (ja) 創傷治癒促進のためのトロンボスポンデインの使用
JP2741767B2 (ja) 器官及び器官の部分の癒着防止用組成物
Berkesoglu et al. Topical application of high-dose mesna prevents adhesion formation: an experimental animal study
US5589169A (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
EP1001790B1 (en) Compositions for lubricating and separating tissues and biological membranes
Mammdoh et al. Effect of topical serratiopeptidase on facial wound healing in rabbit
Scher et al. Effect of cephalosporins on fascial healing after celiotomy
US20130259854A1 (en) Methods and compositions for reducing the incidence of post-surgical adhesions
Lee et al. Effects of Melatonin on Preventing Postoperative Intraperitoneal Adhesion Formation in Rats